MRSA drug gains approval through govt’s rapid process … Kindred blasts Gentiva over ‘poison pill’ … Improved vision increases seniors’ fall risk? … Observation...
Omnicare extends purchase offer for PharMerica until January
Dec 07, 2011
Omnicare announced Monday that it is extending its offer to purchase all outstanding shares of rival PharMerica for $15 per share to Jan. 20. The original offer was scheduled to expire Dec. 2.